Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-185455
Filing Date
2021-06-08
Accepted
2021-06-08 16:35:20
Documents
14
Period of Report
2021-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d188784d8ka.htm   iXBRL 8-K/A 34147
2 EX-99.1 d188784dex991.htm EX-99.1 21117
6 GRAPHIC g16438g0601063358782.jpg GRAPHIC 2475
  Complete submission text file 0001193125-21-185455.txt   199269

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20210601.xsd EX-101.SCH 2723
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20210601_lab.xml EX-101.LAB 19610
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20210601_pre.xml EX-101.PRE 12274
7 EXTRACTED XBRL INSTANCE DOCUMENT d188784d8ka_htm.xml XML 4102
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36156 | Film No.: 211002546
SIC: 8071 Services-Medical Laboratories